Free Trial

ChromaDex (CDXC) News Today

$3.07
-0.12 (-3.76%)
(As of 07/26/2024 ET)
ChromaDex logo with Medical background
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Increases By 68.4%
ChromaDex Co. (NASDAQ:CDXC - Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 3,150,000 shares, an increase of 68.4% from the June 30th total of 1,870,000 shares. Currently, 6.5% of the shares of the company are short sold. Based on an average daily volume of 385,100 shares, the days-to-cover ratio is currently 8.2 days.
ChromaDex logo with Medical background
ChromaDex (NASDAQ:CDXC) Share Price Passes Above Two Hundred Day Moving Average of $2.55
ChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average of $2.55
ChromaDex logo with Medical background
ChromaDex Co. (NASDAQ:CDXC) Short Interest Up 10.7% in June
ChromaDex Co. (NASDAQ:CDXC - Get Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 1,870,000 shares, an increase of 10.7% from the May 31st total of 1,690,000 shares. Based on an average trading volume of 323,100 shares, the days-to-cover ratio is currently 5.8 days. Currently, 3.9% of the company's stock are short sold.
ChromaDex logo with Medical background
ChromaDex (NASDAQ:CDXC) Share Price Passes Above 200-Day Moving Average of $2.47
ChromaDex (NASDAQ:CDXC) Stock Crosses Above 200 Day Moving Average of $2.47
ChromaDex (NASDAQ:CDXC) Given "Buy" Rating at Roth Mkm
Roth Mkm reaffirmed a "buy" rating and set a $6.00 price target on shares of ChromaDex in a research report on Wednesday.
ChromaDex (NASDAQ:CDXC) Shares Cross Above Two Hundred Day Moving Average of $2.32
ChromaDex (NASDAQ:CDXC) Shares Cross Above Two Hundred Day Moving Average of $2.32
Compare with Chromadex Corp (CDXC)
Tieton Capital Management LLC Increases Stake in ChromaDex Co. (NASDAQ:CDXC)
Tieton Capital Management LLC raised its position in shares of ChromaDex Co. (NASDAQ:CDXC - Free Report) by 18.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,913,675 shares of the company's stock after buying an addi
ChromaDex Co. (NASDAQ:CDXC) Expected to Earn Q1 2025 Earnings of $0.00 Per Share
ChromaDex Co. (NASDAQ:CDXC - Free Report) - Analysts at Roth Capital decreased their Q1 2025 earnings estimates for shares of ChromaDex in a report issued on Thursday, May 9th. Roth Capital analyst S. Mcgowan now expects that the company will post earnings per share of $0.00 for the quarter, down
ChromaDex's (CDXC) "Buy" Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $6.00 target price on shares of ChromaDex in a research report on Thursday.
ChromaDex Co. (NASDAQ:CDXC) Short Interest Update
ChromaDex Co. (NASDAQ:CDXC - Get Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,480,000 shares, an increase of 12.1% from the March 31st total of 1,320,000 shares. Approximately 3.3% of the company's shares are sold short. Based on an average daily volume of 309,600 shares, the short-interest ratio is presently 4.8 days.
ChromaDex Corporation (CDXC)
ChromaDex (CDXC) Set to Announce Quarterly Earnings on Wednesday
ChromaDex (NASDAQ:CDXC) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588558)
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 12.8%
ChromaDex Co. (NASDAQ:CDXC - Get Free Report) was the target of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,320,000 shares, an increase of 12.8% from the March 15th total of 1,170,000 shares. Approximately 3.0% of the shares of the company are short sold. Based on an average daily trading volume, of 259,700 shares, the short-interest ratio is presently 5.1 days.
ChromaDex (NASDAQ:CDXC) PT Raised to $6.00
Roth Mkm upped their price target on ChromaDex from $4.25 to $6.00 and gave the company a "buy" rating in a report on Tuesday.
3 Chemical Stocks Poised for Gains
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Declines By 9.0%
ChromaDex Co. (NASDAQ:CDXC - Get Free Report) saw a significant decline in short interest in the month of February. As of February 29th, there was short interest totalling 1,210,000 shares, a decline of 9.0% from the February 14th total of 1,330,000 shares. Based on an average daily volume of 81,100 shares, the short-interest ratio is currently 14.9 days. Currently, 2.7% of the shares of the company are sold short.
Equities Analysts Offer Predictions for ChromaDex Co.'s FY2025 Earnings (NASDAQ:CDXC)
ChromaDex Co. (NASDAQ:CDXC - Free Report) - Analysts at HC Wainwright issued their FY2025 earnings estimates for ChromaDex in a research note issued to investors on Monday, March 11th. HC Wainwright analyst R. Selvaraju forecasts that the company will earn $0.07 per share for the year. The consen
ChromaDex Co. Forecasted to Earn Q1 2025 Earnings of $0.01 Per Share (NASDAQ:CDXC)
ChromaDex Co. (NASDAQ:CDXC - Free Report) - Investment analysts at Roth Capital issued their Q1 2025 EPS estimates for shares of ChromaDex in a report issued on Thursday, March 7th. Roth Capital analyst S. Mcgowan anticipates that the company will earn $0.01 per share for the quarter. The consens
What Wall Street expects from ChromaDex's earnings
Get ChromaDex News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDXC and its competitors with MarketBeat's FREE daily newsletter.

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

CDXC Media Mentions By Week

CDXC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDXC
News Sentiment

0.46

0.61

Average
Medical
News Sentiment

CDXC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDXC Articles
This Week

5

1

CDXC Articles
Average Week

Get ChromaDex News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDXC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CDXC) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners